Alexander V Kabanov Selected Research

Alexander V Kabanov Research Topics

Disease

47	Neoplasms (Cancer) 01/2022 - 08/2002
13	Parkinson Disease (Parkinson's Disease) 03/2022 - 09/2007
11	Inflammation (Inflammations) 04/2021 - 12/2006
9	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2005
6	Obesity 04/2022 - 04/2010
6	Carcinoma (Carcinomatosis) 07/2019 - 08/2006
6	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2017 - 01/2004
6	Ovarian Neoplasms (Ovarian Cancer) 11/2013 - 08/2011
5	Brain Neoplasms (Brain Tumor) 01/2022 - 05/2015
5	Infections 01/2022 - 03/2011
4	Neuroinflammatory Diseases 12/2019 - 09/2011
3	Triple Negative Breast Neoplasms 01/2022 - 01/2020
3	Encephalitis (Encephalitis, Rasmussen) 12/2019 - 05/2007
3	Disease Progression 01/2019 - 04/2010
3	Glioma (Gliomas) 11/2016 - 05/2015
2	Medulloblastoma 01/2022 - 01/2021
2	COVID-19 01/2022 - 01/2021
2	Uveitis 04/2021 - 01/2015
2	Hyperemia 04/2021 - 01/2015
2	Edema (Dropsy) 04/2021 - 01/2015
2	Neoplasm Metastasis (Metastasis) 03/2021 - 01/2018
2	Adenocarcinoma of Lung 03/2021 - 01/2020
2	Non-alcoholic Fatty Liver Disease 01/2020 - 01/2019
2	Central Nervous System Diseases (CNS Diseases) 10/2017 - 09/2014
2	Ischemia 06/2016 - 01/2016
2	Hyperthermia 12/2015 - 04/2014
2	Heart Failure 08/2014 - 08/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 08/2014 - 08/2010
2	Hypertension (High Blood Pressure) 08/2014 - 08/2010
2	Leukemia 01/2013 - 11/2008
2	Adenocarcinoma 01/2013 - 10/2009
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Eye Diseases (Eye Disease) 04/2021
1	Blindness (Hysterical Blindness) 04/2021
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2021

Drug/Important Bio-Agent (IBA)

40	Pharmaceutical PreparationsIBA 01/2022 - 09/2002
22	Poloxamer (Poloxamer 407)IBA 04/2022 - 08/2002
16	MicellesIBA 01/2022 - 12/2004
12	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 08/2003
10	EnzymesIBA 04/2021 - 08/2010
9	AntioxidantsIBA 04/2021 - 09/2007
9	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2006
9	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 08/2002
8	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 08/2014
8	PolymersIBA 11/2013 - 03/2006
7	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 08/2006
7	CatalaseIBA 09/2017 - 01/2011
6	NanogelsIBA 05/2015 - 09/2005
4	LeptinIBA 04/2022 - 04/2010
4	Neuroprotective AgentsIBA 03/2022 - 01/2014
4	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 03/2022 - 01/2014
4	poly(2-oxazoline)IBA 03/2021 - 01/2019
4	ZincIBA 01/2019 - 08/2014
4	CopperIBA 01/2019 - 08/2014
4	Superoxide DismutaseIBA 01/2019 - 08/2014
4	polyethylene glycol polyethyleneimine nanogelIBA 05/2015 - 09/2005
3	Superoxide Dismutase-1IBA 04/2021 - 08/2010
3	Therapeutic UsesIBA 03/2021 - 11/2013
3	Biological ProductsIBA 03/2021 - 08/2011
3	PlatinumIBA 01/2020 - 11/2013
3	SP 1049CIBA 01/2020 - 11/2008
3	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 03/2006
3	Anti-Bacterial Agents (Antibiotics)IBA 12/2014 - 09/2002
3	Folic Acid (Vitamin M)FDA LinkGeneric 11/2013 - 09/2005
3	Ethylene Oxide (Oxirane)IBA 05/2010 - 01/2005
2	remdesivirIBA 01/2022 - 01/2021
2	FibrinIBA 04/2021 - 01/2015
2	Membrane Proteins (Integral Membrane Proteins)IBA 07/2019 - 05/2015
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 02/2018 - 11/2016
2	Drug CombinationsIBA 01/2018 - 11/2013
2	Liposomes (Liposome)IBA 11/2016 - 05/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2016 - 05/2015
2	Monoclonal AntibodiesIBA 05/2015 - 05/2015
2	Superoxides (Superoxide)IBA 08/2014 - 08/2010
2	Angiotensin IIIBA 08/2014 - 08/2010
2	methacrylic acidIBA 01/2012 - 02/2010
2	polypropylene glycol (poly(propylene oxide))IBA 05/2010 - 01/2005
2	Adenosine Triphosphate (ATP)IBA 05/2010 - 08/2003
2	Surface-Active Agents (Surfactants)IBA 11/2008 - 12/2004
2	AnthracyclinesIBA 08/2003 - 09/2002
1	Small Cytoplasmic RNAIBA 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	palbociclibIBA 01/2022
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 01/2022
1	sapanisertibIBA 01/2022
1	Ferrosoferric Oxide (Magnetite)FDA Link 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	AerosolsIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2021
1	NucleosidesIBA 01/2021
1	HhAntag691IBA 01/2021
1	triphosphoric acid (triphosphate)IBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	resiquimodIBA 01/2020
1	NAD (NADH)IBA 01/2020

Therapy/Procedure

23	Therapeutics 01/2022 - 05/2007
12	Drug Therapy (Chemotherapy) 01/2020 - 08/2003
2	Art Therapy 03/2011 - 05/2007
1	Precision Medicine 01/2022
1	Intravenous Injections 03/2021